✦ LIBER ✦

Automated processing of fluorescence in-situ hybridization slides for HER2 testing in breast and gastro-esophageal carcinomas

✍ Scribed by Tafe, Laura J.; Allen, Samantha F.; Steinmetz, Heather B.; Dokus, Betty A.; Cook, Leanne J.; Marotti, Jonathan D.; Tsongalis, Gregory J.

Book ID: 125793464
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 433 KB
Volume: 97
Category: Article
ISSN: 0014-4800
DOI: 10.1016/j.yexmp.2014.06.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

733 HER2 status in breast carcinomas: co

733 HER2 status in breast carcinomas: comparison between silver in situ hybridization, chromogenic in situ hybridization and fluorescence in situ hybridization

✍ S.A. Md Ali; H.M. Nurhayati; M.A. Munirah; M.Z. Reena; N. Masir; S.F. Chandramay 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Comparison of HER-2 status determined by

Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma

✍ Yun Gong; Daniel J. Booser; Nour Sneige 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

## Abstract ## BACKGROUND Accurate assessment of __HER‐2__ status is necessary prior to anti‐__HER‐2__ antibody (trastuzumab) therapy for metastatic breast carcinoma. However, controversy exists regarding whether to assess __HER‐2__ status in the primary tumor or in metastatic lesions. It is also

Comparison of dual-color in-situ hybridi

Comparison of dual-color in-situ hybridization and fluorescence in-situ hybridization in HER2 gene amplification in breast cancer

✍ Rie Horii, Masaaki Matsuura, Takuji Iwase, Yoshinori Ito, Futoshi Akiyama 📂 Article 📅 2013 🏛 Springer Japan 🌐 English ⚖ 588 KB

P25 HER2 Testing in 538 consecutive brea

P25 HER2 Testing in 538 consecutive breast cancer cases using immunohistochemistry and fluorescence in situ hybridization

✍ A. Kovács; G. Stenman 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Comparison of dual-colour chromogenic in

Comparison of dual-colour chromogenic in-situ hybridization and fluorescence in-situ hybridization in the assessment of HER2 gene amplification in breast carcinoma

✍ Susan Conlon; Aoife Colgan; David Allen; Anthony O’Grady; Elaine W Kay 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB

Comparison of PathVysion and INFORM fluo

Comparison of PathVysion and INFORM fluorescence in situ hybridization kits for assessment of HER-2/neu status in breast carcinoma

✍ Kakar, S 📂 Article 📅 2000 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 990 KB